Rebecca Byam - 30 Aug 2022 Form 4 Insider Report for HCW Biologics Inc. (HCWB)

Role
Chief Financial Officer
Signature
/s/ Nicole Valdivieso, as Attorney-in-Fact for Rebecca A. Byam
Issuer symbol
HCWB
Transactions as of
30 Aug 2022
Net transactions value
+$43,913
Form type
4
Filing time
01 Sep 2022, 16:01:46 UTC
Previous filing
30 Aug 2022
Next filing
14 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCWB Common Stock Purchase $18,341 +7,200 +2.7% $2.55 272,952 30 Aug 2022 Direct F1
transaction HCWB Common Stock Purchase $25,572 +10,000 +3.7% $2.56 282,952 31 Aug 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The range of prices for the shares of Common Stock is from $2.53 to $2.56. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F2 The range of prices for the shares of Common Stock is from $2.56 to $2.58. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.